Contraindication/Precautions

Contraindicated in:

• Hypersensitivity

• Systemic infections

• Underlying immunodeficiency, including HIV infection

• Lactation: Discontinue breast-feeding during and for 3 mos following last dose of alemtuzumab

• Patients with ischemic heart disease or in patients on antihypertensive medications

• Women and men with reproduction potential should use contraception during treatment and for 6 mos after therapy

• OB: Should be administered only if clearly needed

alemtuzumab is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.